The Company had $10.3 million in cash, investments and accrued interest receivable as of September 30, 2024. The Company believes it has sufficient capital resources to fund its operations into the third quarter of 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IMNN:
- Imunon, Inc. (IMNN) Q3 Earnings Cheat Sheet
- Imunon to present Phase 2 data of IMNN-001
- Imunon reports inducement grant under NASDAQ listing rule
- Imunon Welcomes Susan Eylward as General Counsel, Strengthens Leadership Team
- Imunon initiated with a Buy at EF Hutton
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
